Antitumor activity of capecitabine and bevacizumab combination in a human estrogen receptor-negative breast adenocarcinoma xenograft model.

Source:http://linkedlifedata.com/resource/pubmed/id/17695515

Download in:

View as

General Info

PMID
17695515